Levels of oxidative stress in patients with neoadjuvant chemotherapy for gastric cancer: correlation with treatment response

被引:3
作者
Lu, Jiatong [1 ]
Guan, Shaoyu [2 ]
Luo, Jiajun [1 ,3 ]
Yuan, Jingwen [1 ]
Yan, Junfeng [1 ]
Yang, Chen [1 ]
Tong, Qiang [1 ]
机构
[1] Renmin Hosp Wuhan Univ, Dept Gastrointestinal Surg Sect 1, Wuhan, Peoples R China
[2] 93868 Troop Chinese Peoples Liberat Army PLA, Yinchuan, Peoples R China
[3] Jianghan Univ, Hosp Wuhan 6, Affiliated Hosp, Dept Gastrointestinal Surg, Wuhan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金
中国国家自然科学基金;
关键词
gastric cancer; oxidative stress; neoadjuvant chemotherapy; chemotherapy responsiveness; predictors; FREE-RADICALS; GLUTATHIONE; RADIATION; APOPTOSIS;
D O I
10.3389/fonc.2023.1192192
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveThe intent of this study was to investigate the relationship between oxidative stress and treatment response in gastric cancer patients undergoing neoadjuvant chemotherapy. MethodsBlood samples from 108 patients and 108 healthy subjects were collected, and all patients were enrolled in SOX chemotherapy. The patients received four cycles of neoadjuvant chemotherapy. Blood samples were collected to determine oxidative stress levels at baseline prior to beginning chemotherapy, and at the end of cycles 2 and 4. The patients receiving neoadjuvant chemotherapy were followed up for several months to years. A survival curve was created according to the follow-up information from the patients. In addition, the correlation between oxidative stress level and treatment effect was evaluated and ROC curves were plotted according to the final collected data. ResultsCompared with the normal group, the levels of the antioxidant index decreased while the peroxide index increased in the patients. Conversely, when patients were compared before and after chemotherapy, the antioxidant index increased but the peroxide index decreased. Furthermore, the antioxidant index increased in the response group while the peroxide index decreased in the non-response group. ConclusionPatients with an increased antioxidant index after chemotherapy have good treatment responsiveness. These indicators can also be used as predictors to judge the patients' response to chemotherapy.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer
    Qu, Jianjun
    Qu, Xiangyang
    CANCER BIOMARKERS, 2016, 17 (01) : 49 - 54
  • [2] Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients
    Yonemura, Y
    Kinoshita, K
    Fujimura, T
    Fushida, S
    Sawa, T
    Matsuki, N
    Tanaka, S
    Kamata, T
    Takashima, T
    Miyazaki, I
    HEPATO-GASTROENTEROLOGY, 1996, 43 (11) : 1260 - 1272
  • [3] Pathologic Response Rates in Patients with Gastric Cancer Following FLOT Neoadjuvant Chemotherapy
    Sajjadi, Samaneh
    Kamandi, Mostafa
    Allahyari, Abolghasem
    Azimi, Sajjad Ataei
    Baari, Alireza
    Valizadeh, Niloufar
    Hatami, Farbod
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2024, 17 (01)
  • [4] A preliminary evaluation of oxidative stress in patients with gastric cancer before chemotherapy
    Jakubik, Jaroslaw A.
    Kolodziejczyk-Czepas, Joanna
    Kedzierska, Magdalena
    Kaczmarek, Michal
    Nowak, Pawel
    Potemski, Piotr
    Jeziorski, Arkadiusz
    ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (02) : 440 - 447
  • [5] Oxidative stress in non-small cell lung cancer patients after chemotherapy: Association with treatment response
    Gupta, Abhilasha
    Srivastava, Shruti
    Prasad, Rajendra
    Natu, Shanker M.
    Mittal, Balraj
    Negi, Mahendra P. S.
    Srivastava, Anand N.
    RESPIROLOGY, 2010, 15 (02) : 349 - 356
  • [6] Systemic inflammatory response markers for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer
    Skorzewska, Magdalena
    Pikula, Agnieszka
    Geca, Katarzyna
    Mlak, Radoslaw
    Rawicz-Pruszynski, Karol
    Sedlak, Katarzyna
    Pasnik, Iwona
    Polkowski, Wojciech P.
    CYTOKINE, 2023, 172
  • [7] Correlation between Skeletal Muscle Mass and Adverse Events of Neoadjuvant Chemotherapy in Patients with Gastric Cancer
    Matsuura, Norihiro
    Motoori, Masaaki
    Fujitani, Kazumasa
    Nishizawa, Yujiro
    Komatsu, Hisateru
    Miyazaki, Yasuhiro
    Miyazaki, Susumu
    Tomokuni, Akira
    Komori, Takamichi
    Iwase, Kazuhiro
    ONCOLOGY, 2020, 98 (01) : 29 - 34
  • [8] Response Evaluation after Neoadjuvant Chemotherapy for Resectable Gastric Cancer
    Sando, Alina Desiree
    Fougner, Reidun
    Royset, Elin Synnove
    Dai, Hong Yan
    Gronbech, Jon Erik
    Bringeland, Erling Audun
    CANCERS, 2023, 15 (08)
  • [9] Effect of Neoadjuvant Chemotherapy Treatment on Prognosis of Patients with Advanced Gastric Cancer:a Retrospective Study
    Shu-bo Tian
    Jian-chun Yu
    Wei-ming Kang
    Zhi-qiang Ma
    Xin Ye
    Chao Yan
    Ya-kai Huang
    ChineseMedicalSciencesJournal, 2015, 30 (02) : 84 - 89
  • [10] Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer
    Wang, Lin Bo
    Teng, Rong Yue
    Jiang, Zi Nong
    Hu, Wen Xian
    Dong, Min Jun
    Yuan, Xiao Ming
    Chen, Wen Jun
    Jin, Mei
    Shen, Jian Guo
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 105 (03) : 293 - 296